Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Iron
Drug ID BADD_D01197
Description A metallic element found in certain minerals, in nearly all soils, and in mineral waters. It is an essential constituent of hemoglobin, cytochrome, and other components of respiratory enzyme systems. Its chief functions are in the transport of oxygen to tissue (hemoglobin) and in cellular oxidation mechanisms. Depletion of iron stores may result in iron-deficiency anemia. Iron is used to build up the blood in anemia.
Indications and Usage Used in preventing and treating iron-deficiency anemia.
Marketing Status approved
ATC Code Not Available
DrugBank ID DB01592
KEGG ID Not Available
MeSH ID D007501
PubChem ID 23925
TTD Drug ID D0Y3TM
NDC Product Code 0220-2054; 62106-5042; 68428-383; 64117-791; 0220-2051; 0164-1152
UNII E1UOL152H7
Synonyms Iron | Iron-56 | Iron 56
Chemical Information
Molecular Formula Fe
CAS Registry Number 7439-89-6
SMILES [Fe]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Therapeutic reaction time decreased08.06.01.015--Not Available
Decreased appetite14.03.01.005; 08.01.09.0280.001904%
Feeling of body temperature change08.01.09.012--Not Available
Ill-defined disorder08.01.03.049--Not Available
Inner ear disorder04.04.02.002--Not Available
Polyp08.01.06.010; 16.02.02.005--Not Available
Sensation of foreign body08.01.09.002--Not Available
Blood disorder01.05.01.0040.000453%Not Available
Drug intolerance08.06.01.013--Not Available
Sinus disorder22.04.06.0020.000907%
Poor quality sleep19.02.05.005; 17.15.04.002--Not Available
Bowel movement irregularity07.02.03.003--Not Available
Gastrointestinal inflammation07.08.03.0070.000453%Not Available
Infusion site urticaria10.01.06.010; 08.02.05.021; 23.04.02.010; 12.07.05.021--Not Available
Iron overload14.13.03.002; 12.02.08.005--
Regurgitation07.01.07.004--Not Available
Gastrointestinal sounds abnormal07.01.01.002--Not Available
Oropharyngeal discomfort07.05.05.008; 22.12.03.015--Not Available
Oropharyngeal pain22.12.03.016; 07.05.05.004--
Acute kidney injury20.01.03.0160.000680%
Posterior reversible encephalopathy syndrome17.13.02.0070.000453%
Slow speech19.19.02.004; 17.02.08.016--Not Available
Faeces soft07.01.03.008--Not Available
Mouth swelling10.01.05.020; 23.04.01.020; 07.05.04.007--Not Available
Anal incontinence17.05.01.021; 07.01.06.029--
Normal newborn18.08.06.0010.000680%Not Available
Rash papulosquamous23.03.08.0140.000453%Not Available
Biliary dyskinesia09.03.02.0040.000453%Not Available
Neurogenic shock24.06.02.023; 17.02.10.025--Not Available
Pharyngeal hypoaesthesia22.04.05.017; 17.02.06.034--Not Available
The 13th Page    First    Pre   13 14    Next   Last    Total 14 Pages